JMP Securities Reiterates Market Outperform on Ocular Therapeutix, Maintains $12 Price Target
JMP Securities analyst Jonathan Wolleben reiterates Ocular Therapeutix (NASDAQ:OCUL) with a Market Outperform and maintains $12 price target.
Benchmark Reiterates Buy on Quipt Home Medical, Maintains $10 Price Target
Benchmark analyst Bill Sutherland reiterates Quipt Home Medical (NASDAQ:QIPT) with a Buy and maintains $10 price target.
Benchmark Reiterates Buy on Amedisys, Maintains $120 Price Target
Benchmark analyst Bill Sutherland reiterates Amedisys (NASDAQ:AMED) with a Buy and maintains $120 price target.
Benchmark Reiterates Buy on Proto Labs, Maintains $45 Price Target
Benchmark analyst Robert Wasserman reiterates Proto Labs (NYSE:PRLB) with a Buy and maintains $45 price target.
Stephens & Co. Reiterates Equal-Weight on Fidelity National Info, Maintains $80 Price Target
Stephens & Co. analyst Charles Nabhan reiterates Fidelity National Info (NYSE:FIS) with a Equal-Weight and maintains $80 price target.
HC Wainwright & Co. Reiterates Buy on Ur-Energy, Maintains $3 Price Target
HC Wainwright & Co. analyst Heiko Ihle reiterates Ur-Energy (AMEX:URG) with a Buy and maintains $3 price target.
HC Wainwright & Co. Reiterates Buy on Northern Dynasty Minerals, Maintains $0.8 Price Target
HC Wainwright & Co. analyst Heiko Ihle reiterates Northern Dynasty Minerals (AMEX:NAK) with a Buy and maintains $0.8 price target.
HC Wainwright & Co. Reiterates Buy on Shattuck Labs, Maintains $28 Price Target
HC Wainwright & Co. analyst Joseph Pantginis reiterates Shattuck Labs (NASDAQ:STTK) with a Buy and maintains $28 price target.
Cowen & Co. Reiterates Outperform on Chipotle Mexican Grill, Maintains $2050 Price Target
Cowen & Co. analyst Andrew Charles reiterates Chipotle Mexican Grill (NYSE:CMG) with a Outperform and maintains $2050 price target.
Chardan Capital Reiterates Buy on PLBY Group, Maintains $5 Price Target
Chardan Capital analyst Brian Dobson reiterates PLBY Group (NASDAQ:PLBY) with a Buy and maintains $5 price target.